Correction: Effects of cancer screening restart strategies after COVID-19 disruption.

Kregting, Lindy M; Kaljouw, Sylvia; de Jonge, Lucie; Jansen, Erik E L; Peterse, Elisabeth F P; Heijnsdijk, Eveline A M; van Ravesteyn, Nicolien T; Lansdorp-Vogelaar, Iris; de Kok, Inge M C M

Kregting, Lindy M; Kaljouw, Sylvia; de Jonge, Lucie; Jansen, Erik E L; Peterse, Elisabeth F P; Heijnsdijk, Eveline A M; van Ravesteyn, Nicolien T; Lansdorp-Vogelaar, Iris; de Kok, Inge M C M.

Kregting LM; Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, The Netherlands. l.kregting@erasmusmc.nl.
Kaljouw S; Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
de Jonge L; Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
Jansen EEL; Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
Peterse EFP; Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
Heijnsdijk EAM; Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
van Ravesteyn NT; Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
Lansdorp-Vogelaar I; Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
de Kok IMCM; Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.

Br J Cancer ; 125(1): 145, 2021 Jul.

Article in English | MEDLINE | ID: covidwho-1237994

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies Language: English Journal: Br J Cancer Year: 2021 Document Type: Article Affiliation country: S41416-021-01427-5

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google